Commercial:
Further to the trade presentations in 2006 and the announcement of the granting of an exclusive worldwide licence to a major international medical device and component manufacturer, tooling for commercial quantities of the Luer lock and Luer slip versions is currently being produced and product launch is planned for the fourth quarter of 2008.

Further details regarding the licensee, product versions and availability will be released at the time of the launch.

Technical:
Leading on from the development of standard Luer slip and Luer Lock versions, further work is currently being undertaken to extend the range to include reconstitution devices for lyophilized drugs, versions integrated with pre-fill syringes, and also a version suitable for use with auto-injectors.

Testing:
Recent trials have demonstrated that the Sleeve-Lok needle meets all the requirements of healthcare workers in terms of safety, ease of use, balance, light weight, low operating force and safe disposal. The results also showed that the needle meets all the criteria expected by national and international professional bodies.

Follow this link for a video demonstration of the Salvus needle protecting a user under conditions of severe abuse

Patents:
We currently have patents Granted and pending for proprietary technologies relating to our safety needle technology. The patent portfolio includes pending applications directed to the safety needle itself in the US, Europe and Japan as well as in other countries including Australia, Brazil, China, India and Mexico. Other pending international patent applications protect the active packaging, sealing, and other configurations.